VIVUS, Inc. (NASDAQ:VVUS) reached 10.17% versus a 1-year low price of $0.48. The stock was last seen 5.41% higher, reaching at $0.53 on 01/11/2018. At recent session, the prices were hovering between $0.503 and $0.53. This company shares are 183.02% off its target price of $1.5 and the current market capitalization stands at $57.63M. The recent change has given its price a -11.56% deficit over SMA 50 and -61.6% deficit over its 52-week high. The stock witnessed -8.32% declines, -38.02% declines and -57.61% declines for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found VVUS’s volatility during a week at 5.05% and during a month it has been found around 6.42%.VIVUS, Inc. (VVUS) Top Holders
Institutional investors currently hold around $17 million or 36.8% in VVUS stock. Look at its top three institutional owners. Renaissance Technologies Llc owns $4.36 million in VIVUS, Inc., which represents roughly 7.57% of the company’s market cap and approximately 25.66% of the institutional ownership. Similar statistics are true for the second largest owner, Credit Suisse Ag/, which owns 3,802,620 shares of the stock are valued at $1.91 million. The third largest holder is Vanguard Group Inc, which currently holds $1.76 million worth of this stock and that ownership represents nearly 3.05% of its market capitalization.
At the end of 09/30/2017 reporting period, 24 institutional holders increased their position in VIVUS, Inc. (NASDAQ:VVUS) by some 2,973,650 shares, 36 decreased positions by 6,788,172 and 26 held positions by 23,823,148. That puts total institutional holdings at 33,584,970 shares, according to SEC filings. The stock grabbed 6 new institutional investments totaling 843,570 shares while 12 institutional investors sold out their entire positions totaling 5,390,032 shares.VIVUS, Inc. (NASDAQ:VVUS) Insider Trades
Multiple company employees have indulged in significant insider trading. VIVUS, Inc. disclosed in a document filed with the US Securities and Exchange Commission (SEC) that Chief Medical Officer Varghese Santosh T has sold 444 shares of VIVUS, Inc. (VVUS) in trading session dated Jan. 01, 2018. These shares are worth $226 and were traded at $0.51 each. The SEC filing shows that Varghese Santosh T performed a sale of 434 shares. The Chief Medical Officer disposed these shares by way of transaction on Oct. 03, 2017. The company’s shares were given away at $0.97 per share worth to an income of some $421 on account of Varghese Santosh T.
Chief Medical Officer, Varghese Santosh T, sold 423 common shares of VIVUS, Inc. (VVUS) in the open market. In a transaction dated Jul. 03, 2017, the shares were put up for sale at an average price of $1.23, raking in a sum of $520. After this sale, 73,174 common shares of VVUS are directly owned by the insider, with total stake valued at $38,782.
In the transaction dated Apr. 04, 2017, the great number of shares disposed came courtesy the Chief Medical Officer; Varghese Santosh T disposed a total of 440 shares at an average price of $1.08, amounting to approximately $475. The insider now directly owns 73,597 shares worth $39,006.VIVUS, Inc. (VVUS) Analyst Guide
Several analysts have released their opinion on VIVUS, Inc. (NASDAQ:VVUS), with 0 analysts believing it is a strong buy. Whereas 1 of them predict the stock is a hold. Also, there are 0 buy, 0 sell and 0 strong sell ratings, collectively assigning a 3 average brokerage recommendation.